May 25th, 2022 (Earnings Report) Dear Reader,
HealthTechMovers.com just identified several healthtech stocks that are expected to release earnings starting today, July 18th. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Artelo Biosciences
Symbol: ARTL
Recent Price: $0.34
Average Analyst Price Target: $4.00 (1076.47%)
Last Year's EPS: -$0.1
Consensus EPS Forecast: -$0.06
Expected Earnings Date: Jul 18 2022
Recent Analyst Action: Michael Higgins, analyst at Ladenburg Thalmann & Co., reiterates coverage on Artelo Biosciences (ARTL) in the Healthcare sector with a Buy rating and a price target of $ 4 (2 weeks ago).
Click for complete article >>--------------------------------------------------------------------------
Johnson & Johnson
Symbol: JNJ
Recent Price: $178.23
Average Analyst Price Target: $192.50 (8.01%)
Last Year's EPS: $2.48
Consensus EPS Forecast: $2.54
Expected Earnings Date: Jul 18 2022
Recent Analyst Action: Larry Biegelsen, analyst at Wells Fargo, reiterates coverage on Johnson & Johnson (JNJ) in the Healthcare sector with a Buy rating and a price target of $ 195 (4 days ago).
Click for complete article >>--------------------------------------------------------------------------
Biotage AB
Symbol: BITGF
Recent Price: $17
Average Analyst Price Target: $23.78 (39.88%)
Last Year's EPS: $0.07
Consensus EPS Forecast: $0.08
Expected Earnings Date: Jul 18 2022
Recent Analyst Action: Odysseas Manesiotis, analyst at Berenberg Bank, reiterates coverage on Biotage AB (BITGF) in the Healthcare sector with a Buy rating and a price target of $ 25.07 (1 week ago).
Click for complete article >>--------------------------------------------------------------------------
Abbott Labs
Symbol: ABT
Recent Price: $108.82
Average Analyst Price Target: $128.08 (17.70%)
Last Year's EPS: $1.17
Consensus EPS Forecast: $1.13
Expected Earnings Date: Jul 19 2022
Recent Analyst Action: Jayson Bedford, analyst at Raymond James, reiterates coverage on Abbott Labs (ABT) in the Healthcare sector with a Buy rating and a price target of $ 117 (2 days ago).
Click for complete article >>--------------------------------------------------------------------------
Biogen
Symbol: BIIB
Recent Price: $217.01
Average Analyst Price Target: $245.95 (13.34%)
Last Year's EPS: $5.68
Consensus EPS Forecast: $4.14
Expected Earnings Date: Jul 19 2022
Recent Analyst Action: Brian Skorney, analyst at Robert W. Baird, reiterates coverage on Biogen (BIIB) in the Healthcare sector with a Hold rating and a price target of $ 224 (5 days ago).
Click for complete article >>--------------------------------------------------------------------------
Elevance Health
Symbol: ELV
Recent Price: $488.92
Average Analyst Price Target: $568.40 (16.26%)
Last Year's EPS: $7.03
Consensus EPS Forecast: $7.75
Expected Earnings Date: Jul 19 2022
Recent Analyst Action: Ricky Goldwasser, analyst at Morgan Stanley, reiterates coverage on Elevance Health (ELV) in the Healthcare sector with a Hold rating and a price target of $ 533 (3 weeks ago).
Click for complete article >>--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com